Literature DB >> 21641393

Changes in autophagic response in patients with chronic hepatitis C virus infection.

Pierre-Emmanuel Rautou1, Dominique Cazals-Hatem, Gérard Feldmann, Abdellah Mansouri, Alain Grodet, Sandrine Barge, Michèle Martinot-Peignoux, Aurélie Duces, Ivan Bièche, Didier Lebrec, Pierre Bedossa, Valérie Paradis, Patrick Marcellin, Dominique Valla, Tarik Asselah, Richard Moreau.   

Abstract

Autophagy is a regulated process that can be involved in the elimination of intracellular microorganisms and in antigen presentation. Some in vitro studies have shown an altered autophagic response in hepatitis C virus infected hepatocytes. The present study aimed at evaluating the autophagic process in the liver of chronic hepatitis C (CHC) patients. Fifty-six CHC patients and 47 control patients (8 with nonalcoholic steatohepatitis or alcoholic liver disease, 18 with chronic heptatitis B virus infection, and 21 with no or mild liver abnormalities at histological examination) were included. Autophagy was assessed by means of electron microscopy and microtubule-associated protein light chain 3 immunoblotting. Using light chain 3 immunoblotting, the form present on autophagic vesicle (light chain 3-II) was significantly higher in CHC patients than in controls (P < 0.05). Using quantitative electron microscopy analysis, the median number of autophagic vesicles observed in hepatocytes from CHC patients was sixfold higher than in overall controls (P < 0.001). In contrast, there was no difference between CHC patients and controls in the number of mature lysosomes with electron-dense contents arguing in favor of a lack of fusion between autophagosome and lysosome. Neither genotype nor viral load influenced the autophagy level. In conclusion, autophagy is altered in hepatocytes from CHC patients, likely due to a blockade of the last step of the autophagic process.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641393      PMCID: PMC3124343          DOI: 10.1016/j.ajpath.2011.02.021

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

Review 2.  Maturation of autophagic vacuoles in Mammalian cells.

Authors:  Eeva-Liisa Eskelinen
Journal:  Autophagy       Date:  2005-04-28       Impact factor: 16.016

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 4.  Autophagy in liver diseases.

Authors:  Pierre-Emmanuel Rautou; Abdellah Mansouri; Didier Lebrec; François Durand; Dominique Valla; Richard Moreau
Journal:  J Hepatol       Date:  2010-08-01       Impact factor: 25.083

5.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

6.  Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro.

Authors:  Po-Yuan Ke; Steve S-L Chen
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

7.  Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles.

Authors:  Isei Tanida; Masayoshi Fukasawa; Takashi Ueno; Eiki Kominami; Takaji Wakita; Kentaro Hanada
Journal:  Autophagy       Date:  2009-10-10       Impact factor: 16.016

Review 8.  Autophagy in the pathogenesis of disease.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

9.  Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection.

Authors:  Carl Guévin; David Manna; Claudia Bélanger; Kouacou V Konan; Paul Mak; Patrick Labonté
Journal:  Virology       Date:  2010-06-26       Impact factor: 3.616

10.  Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy.

Authors:  Tomokazu Mizui; Shunhei Yamashina; Isei Tanida; Yoshiyuki Takei; Takashi Ueno; Naoya Sakamoto; Kenichi Ikejima; Tsuneo Kitamura; Nobuyuki Enomoto; Tatsuo Sakai; Eiki Kominami; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2009-09-17       Impact factor: 7.527

View more
  27 in total

Review 1.  Autophagy in the liver: functions in health and disease.

Authors:  Takashi Ueno; Masaaki Komatsu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 2.  It's a cell-eat-cell world: autophagy and phagocytosis.

Authors:  Elizabeth A Oczypok; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2013-01-29       Impact factor: 4.307

Review 3.  Targeting autophagy for the treatment of liver diseases.

Authors:  Hong-Min Ni; Jessica A Williams; Hua Yang; Ying-Hong Shi; Jia Fan; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2012-07-31       Impact factor: 7.658

4.  Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model.

Authors:  Sylvie Lagaye; Sonia Brun; Jesintha Gaston; Hong Shen; Ruzena Stranska; Claire Camus; Clarisse Dubray; Géraldine Rousseau; Pierre-Philippe Massault; Jerôme Courcambeck; Firas Bassisi; Philippe Halfon; Stanislas Pol
Journal:  World J Hepatol       Date:  2016-07-28

5.  Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.

Authors:  Rajesh Panigrahi; Partha K Chandra; Pauline Ferraris; Ramazan Kurt; Kyoungsub Song; Robert F Garry; Krzysztof Reiss; Imogen R Coe; Tomomi Furihata; Luis A Balart; Tong Wu; Srikanta Dash
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 6.  Hepatitis C virus and autophagy.

Authors:  Linya Wang; Jing-hsiung James Ou
Journal:  Biol Chem       Date:  2015-11       Impact factor: 3.915

7.  HCV infection selectively impairs type I but not type III IFN signaling.

Authors:  Partha K Chandra; Lili Bao; Kyoungsub Song; Fatma M Aboulnasr; Darren P Baker; Nathan Shores; William C Wimley; Shuanghu Liu; Curt H Hagedorn; Serge Y Fuchs; Tong Wu; Luis A Balart; Srikanta Dash
Journal:  Am J Pathol       Date:  2013-11-09       Impact factor: 4.307

8.  Impaired autophagy response in human hepatocellular carcinoma.

Authors:  Lili Bao; Partha K Chandra; Krzysztof Moroz; Xuchen Zhang; Swan N Thung; Tong Wu; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-12-23       Impact factor: 3.362

Review 9.  Functions of autophagy in normal and diseased liver.

Authors:  Mark J Czaja; Wen-Xing Ding; Terrence M Donohue; Scott L Friedman; Jae-Sung Kim; Masaaki Komatsu; John J Lemasters; Antoinette Lemoine; Jiandie D Lin; Jing-hsiung James Ou; David H Perlmutter; Glenn Randall; Ratna B Ray; Allan Tsung; Xiao-Ming Yin
Journal:  Autophagy       Date:  2013-05-22       Impact factor: 16.016

10.  Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.

Authors:  Ozge Cevik; Dan Li; Erdene Baljinnyam; Dinesh Manvar; Erica M Pimenta; Gulam Waris; Betsy J Barnes; Neerja Kaushik-Basu
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.